Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens
Open Access
Abstract
Chlamydia is the most common cause of bacterial sexually transmitted infections worldwide. While infections resolve with antibiotic treatment, this is often neglected in women due to frequent asymptomatic infections, leading to disease progression and severe sequelae (pelvic inflammatory disease, ectopic pregnancy, infertility). Development of a vaccine against Chlamydia is crucial. Whole organism-based vaccines have short-lived activity, serovar/subgroup-specific immunity and can cause adverse reactions in vaccinated subjects. The Chlamydia major outer membrane protein (MOMP) is a prime candidate for a subunit vaccine. MOMP contains four regions of sequence variability (variable domains, VDs) with B-cell and T-cell epitopes that elicit protective immunity. However, barriers for developing a MOMP-based vaccine include solubility, yield and refolding. We have engineered novel recombinant antigens in which the VDs are expressed into a carrier protein structurally similar to MOMP and suitable for recombinant expression at a high yield in a correctly folded and detergent-free form. Using a carrier such as the PorB porin from the human commensal organism N. lactamica, we show that PorB/VD chimeric proteins are immunogenic, antigenic and cross-reactive with MOMP. VDs are unique for each serovar but if combined in a single vaccine, a broad coverage against the major Chlamydia serovars can be ensured.Keywords
Funding Information
- National Institutes of Health (R03 1R03AI123885-01, R01 GM 067260)
- SutroVax
This publication has 83 references indexed in Scilit:
- Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccineInternational Journal of Nanomedicine, 2013
- Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccineVaccine, 2011
- Human Airway Epithelial Cell Responses to Neisseria lactamica and Purified Porin via Toll-Like Receptor 2-Dependent SignalingInfection and Immunity, 2010
- CD4+T Cells and Antibody Are Required for Optimal Major Outer Membrane Protein Vaccine-Induced Immunity toChlamydia muridarumGenital InfectionInfection and Immunity, 2010
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorBMicrobiology, 2008
- The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvantVaccine, 2008
- Immunization with LiveNeisseria lactamicaProtects Mice against Meningococcal Challenge and Can Elicit Serum Bactericidal AntibodiesInfection and Immunity, 2006
- The SWISS-MODEL workspace: a web-based environment for protein structure homology modellingBioinformatics, 2005
- Multiple sequence alignment with the Clustal series of programsNucleic Acids Research, 2003